Clinical trial
A Prospective Feasibility Study to Evaluate the Safety and Performance of the Exhale(R) Drug-Eluting Stent System in Patients With Emphysema
NCT00207337 is registered in ClinicalTrials.gov with Broncus Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Feasibility Study to Evaluate the Safety and Performance of the Exhale(R) Drug-Eluting Stent System in Patients With Emphysema
- Lead sponsor
- Broncus Technologies
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- May 31, 2006
- Enrollment
- 60
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.